Improving recruitment, efficiency and quality of academic cancer clinical trials in Canada







  • 3CTN Annual Report 2025-26

    3CTN Annual Report 2025-26

    We are proud to present an overview of the Canadian Cancer Clinical Trials Network’s (3CTN) accomplishments and progress made throughout the 2025-2026 fiscal year. Read about the Impact of 3CTN’s Academic Clinical Trial Portfolio, Advancing Equity in Cancer Clinical Trials, the Incoming Chair of the Patient Representative Advisory Sub-Committee, the 3CTN Travel and Education Grant,…

  • Portfolio Watch September 2026

    Portfolio Watch September 2026

    This issue contains 4 new trials , 2 practice changing trials, the Y13Q1 recruitment performance report and portfolio trial publications.

  • EDGE Essentials August 2026

    EDGE Essentials August 2026

    This edition explores how EDGE helps clinical research teams track trial progress, review historical changes, monitor study activities, and maintain continuity throughout a study. It highlights tools such as audit trails, timelines, calendars, workflows, and notes that support oversight, compliance, and efficient study management.


Our Partners


Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.